St John's Wort Extract Supplement - Natural Anti-Depressant for Emotional Well-Being

St. John's Wort is a natural effective alternative for depression to the addictive and handicapping chemical straight jackets.

What do studies show about St. John Wort Extract?

It was in Germany that were carried out the first studies showing the effectiveness of St. John's Wort for improving mood. When women aged between 55 and 65 years received St. John's Wort extract as a unique therapy, the modification of the urinary metabolisms indicated an increased cerebral production of dopamine, a normal effect of anti-depressants. The subjective indicators of depression (anxiety, loss of interest, lethargy, anorexia, feeling of uselessness) were also significantly improved.

Other studies proved that St. John's Wort is more effective for depressive symptoms than certain common medication, such as amitriptyline and imipramine. In a recent multi-analysis published by the British Journal of Medicine (1996 : 313 : 253-8), 1.757 patients suffering from light or moderate depression were separated into 23 sub-groups. The results indicated that St. John's Wort extract was at least as effective, and perhaps more effective than conventional approaches. In 1994 the Journal of Geriatric Psychiatry and Neurology dedicated a whole issue to 17 studies documenting the value of St. John's Wort in cases of light or moderate depression. Conclusion of the Journal: St. John's Wort is a natural anti-depressant remarkably lacking in side effects.

1. Busser, C. et E., Les plantes des Vosges Médecine et traditions populaires. Strasbourg, La Nuée Bleue, 2005, 160-162.
2. Bruneton J., Pharmacognosie, phytochimie, plantes médicinales. Paris, Editions Tec
3. & Doc, 1999, 3e édition, 440-445.
4. Butterweck V. Mechanism of action of St John’s wort in depression : what is known? Institute of Pharmacology and Toxicology, Universitatsklinikum Munster, Germany. CNS Drugs. 2003, 17, 539-562.
5. Linde K, Berner M. and Kriston L. St John’s wort for major depression (Review). The Cochrane Library. 2009, 4, 1-103.
6. Morel J-M. Phytothérapie et troubles psychiatriques : possibilités d’application avec le Millepertuis. La Phytothérapie Européenne. Novembre/Décembre 2005, 8-14.
7. Wonnemann M., Singer A. and Müller W. Inhibition of Synatosomal Uptake of 3 H-Lglutamate and 3 H-GABA by Hyperforin, a Major Constituent of St. John’s Wort : The Role of Amiloride Sensitive Sodium Conductive Pathways. Neuropsychopharmacology. 2000, 23, 188-197
8. Linde K., Ramirez G., Mulrow C., Pauls A., Weidenhammer W. and Melchart D. St John’s wort for depression-an overwiew and meta-analysis of randomised clinical trials. BMJ. 1996, 313, 253-258.
9. Whiskey E., Werneke U. and Taylor D. A systematic review and meta-analysis of Hypericum perforatum in depression : a comprehensive clinical review Intern Clin Psychopharmacology. 2001, 16, 239-252.
10. Linde K, Berner M. and Kriston L. St John’s wort for major depression (Review). The Cochrane Library. 2009, 4, 1-103.
11. Szegedi A., Kohnen R., Dienel A. and Kieser M. Acute treatment of moderate to severe depression with hypericium extract WS 5570 (St John’s wort) : randomised controlled double blind non-inferiority trial versus paroxetine. BMJ. 2005, 330, 503- 507.
12. Morel J-M. Phytothérapie et troubles psychiatriques : possibilités d’application avec le Millepertuis. La Phytothérapie Européenne. Novembre/Décembre 2005, 8-14.